Chalcone Derivatives: Promising Starting Points for Drug Design
暂无分享,去创建一个
Eugene N. Muratov | Bruno J. Neves | Carolina H. Andrade | Maristela Pereira | C. Andrade | E. Muratov | Maristela Pereira | J. C. Peixoto | B. J. Neves | P. Cravo | Marcelo N. Gomes | Josana C. Peixoto | Lucimar P. Rosseto | Pedro V. L. Cravo | M. N. Gomes | L. Rosseto | J. Peixoto | M. Pereira | B. Neves
[1] T. Klabunde. Chemogenomic approaches to drug discovery: similar receptors bind similar ligands , 2007, British journal of pharmacology.
[2] Alexander Tropsha,et al. Trust, but Verify II: A Practical Guide to Chemogenomics Data Curation , 2016, J. Chem. Inf. Model..
[3] Richard D. Taylor,et al. Improved protein–ligand docking using GOLD , 2003, Proteins.
[4] Daniela Schuster,et al. Methods for generating and applying pharmacophore models as virtual screening filters and for bioactivity profiling. , 2015, Methods.
[5] E. Wong. The role of chalcones and flavanones in flavonoid biosynthesis , 1968 .
[6] F. V. van Heerden,et al. Application of the Suzuki-Miyaura Reaction in the Synthesis of Flavonoids , 2013, Molecules.
[7] N. Meanwell. Synopsis of some recent tactical application of bioisosteres in drug design. , 2011, Journal of medicinal chemistry.
[8] M. Kikuchi,et al. Anti-allergic Activity of Naringenin Chalcone from a Tomato Skin Extract , 2004, Bioscience, biotechnology, and biochemistry.
[9] E. LaVoie,et al. Bioisosterism: A Rational Approach in Drug Design. , 1996, Chemical reviews.
[10] Alexander Tropsha,et al. Curation of chemogenomics data. , 2015, Nature chemical biology.
[11] Muriel Hachet-Haas,et al. Prodrugs of a CXC Chemokine-12 (CXCL12) Neutraligand Prevent Inflammatory Reactions in an Asthma Model in Vivo. , 2012, ACS medicinal chemistry letters.
[12] Shinji Ohta,et al. C-geranylated chalcones from the stems of Angelica keiskei with superoxide-scavenging activity. , 2008, Journal of natural products.
[13] S. Rees,et al. Principles of early drug discovery , 2011, British journal of pharmacology.
[14] Kai Huang,et al. PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach , 2010, Nucleic Acids Res..
[15] Subha Kalyaanamoorthy,et al. Modelling and enhanced molecular dynamics to steer structure-based drug discovery. , 2014, Progress in biophysics and molecular biology.
[16] C. Nakamura,et al. Recent advances in leishmaniasis treatment. , 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[17] Diogo Santos-Martins,et al. Receptor-based virtual screening protocol for drug discovery. , 2015, Archives of biochemistry and biophysics.
[18] J. Sikorski,et al. Recent advances in therapeutic chalcones , 2004 .
[19] John B. O. Mitchell. Machine learning methods in chemoinformatics , 2014, Wiley interdisciplinary reviews. Computational molecular science.
[20] David S. Goodsell,et al. The RCSB Protein Data Bank: views of structural biology for basic and applied research and education , 2014, Nucleic Acids Res..
[21] E. Barreiro,et al. Molecular hybridization: a useful tool in the design of new drug prototypes. , 2007, Current medicinal chemistry.
[22] D. Ferry,et al. [3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes. , 1981, Arzneimittel-Forschung.
[23] Leonardo L. G. Ferreira,et al. Molecular Docking and Structure-Based Drug Design Strategies , 2015, Molecules.
[24] Virander S. Chauhan,et al. Mechanism of malarial haem detoxification inhibition by chloroquine. , 2001, The Biochemical journal.
[25] S. Ducki. Antimitotic chalcones and related compounds as inhibitors of tubulin assembly. , 2009, Anti-cancer agents in medicinal chemistry.
[26] A. Magalska,et al. Ciprofloxacin inhibits proliferation and promotes generation of aneuploidy in Jurkat cells. , 2010, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[27] Alexander Tropsha,et al. Trust, But Verify: On the Importance of Chemical Structure Curation in Cheminformatics and QSAR Modeling Research , 2010, J. Chem. Inf. Model..
[28] Patrick Gizzi,et al. Small Neutralizing Molecules to Inhibit Actions of the Chemokine CXCL12* , 2008, Journal of Biological Chemistry.
[29] Ruibo Wu,et al. Computational Design of a Time-Dependent Histone Deacetylase 2 Selective Inhibitor , 2014, ACS chemical biology.
[30] C. Dumontet. Mechanisms of action and resistance to tubulin-binding agents , 2000, Expert opinion on investigational drugs.
[31] U. Rashid,et al. Structure based medicinal chemistry-driven strategy to design substituted dihydropyrimidines as potential antileishmanial agents. , 2016, European journal of medicinal chemistry.
[32] Cristiano Ruch Werneck Guimarães,et al. MM-GB/SA Rescoring of Docking Poses in Structure-Based Lead Optimization , 2008, J. Chem. Inf. Model..
[33] M. Jasamai,et al. Synthesis and biological evaluation of chalcone derivatives (mini review). , 2012, Mini reviews in medicinal chemistry.
[34] C. Wermuth,et al. Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998) , 1998 .
[35] S. Kazda,et al. Pharmacological studies of the antihypertensive effect of nitrendipine. , 1981, Arzneimittel-Forschung.
[36] F. Sarkar,et al. Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis. , 2003, International journal of oncology.
[37] D. Siegel. Comprehensive Organic Name Reactions and Reagents, Volume 1−3 , 2010 .
[38] N. Lajis,et al. Cardamonin inhibits COX and iNOS expression via inhibition of p65NF-κB nuclear translocation and Iκ-B phosphorylation in RAW 264.7 macrophage cells , 2007 .
[39] M. Chung,et al. The Prodrug Approach: A Successful Tool for Improving Drug Solubility , 2015, Molecules.
[40] R J Fletterick,et al. Structure-based design of parasitic protease inhibitors. , 1996, Bioorganic & medicinal chemistry.
[41] S. Sundar,et al. Molecular docking, structure-activity relationship and biological evaluation of the anticancer drug monastrol as a pteridine reductase inhibitor in a clinical isolate of Leishmania donovani. , 2010, The Journal of antimicrobial chemotherapy.
[42] K. Srivastava,et al. Synthesis and in vitro evaluation of new chloroquine-chalcone hybrids against chloroquine-resistant strain of Plasmodium falciparum. , 2012, Bioorganic & medicinal chemistry letters.
[43] Alexander Tropsha,et al. Phantom PAINS: Problems with the Utility of Alerts for Pan-Assay INterference CompoundS , 2017, J. Chem. Inf. Model..
[44] N. Sahu,et al. Exploring pharmacological significance of chalcone scaffold: a review. , 2012, Current medicinal chemistry.
[45] Jahan B Ghasemi,et al. Methods and applications of structure based pharmacophores in drug discovery. , 2013, Current topics in medicinal chemistry.
[46] S. Amslinger,et al. Reactivity assessment of chalcones by a kinetic thiol assay. , 2013, Organic & biomolecular chemistry.
[47] Xiao Yu,et al. Protein Flexibility in Docking-Based Virtual Screening: Discovery of Novel Lymphoid-Specific Tyrosine Phosphatase Inhibitors Using Multiple Crystal Structures , 2015, J. Chem. Inf. Model..
[48] Paolo Massimo Buscema,et al. Similarity Coefficients for Binary Chemoinformatics Data: Overview and Extended Comparison Using Simulated and Real Data Sets , 2012, J. Chem. Inf. Model..
[49] M. Kumar,et al. Synthesis and antihyperlipidemic activity of novel coumarin bisindole derivatives. , 2010, Bioorganic & medicinal chemistry letters.
[50] Vladimir Vapnik,et al. The Nature of Statistical Learning , 1995 .
[51] D. Ribatti,et al. Antivascular and antitumor properties of the tubulin-binding chalcone TUB091 , 2016, Oncotarget.
[52] F. Chang,et al. Continuous-Flow Synthesis of Deuterium-Labeled Antidiabetic Chalcones: Studies towards the Selective Deuteration of the Alkynone Core , 2016, Molecules.
[53] U. Schultz-Ehrenburg,et al. [Controlled study of increasing venous tone in primary varicose veins by oral administration of Ruscus aculeatus and trimethylhespiridinchalcone]. , 1987, Zeitschrift fur Hautkrankheiten.
[54] G. Tsourouflis,et al. Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer. , 2017, Anticancer research.
[55] Maria A Miteva,et al. Pan-assay interference compounds (PAINS) that may not be too painful for chemical biology projects. , 2017, Drug discovery today.
[56] G. Moreau,et al. Rational approach to drug design , 2008 .
[57] Alexander Tropsha,et al. Best Practices for QSAR Model Development, Validation, and Exploitation , 2010, Molecular informatics.
[58] Synthesis and biological evaluation of novel hybrid chalcone derivatives as vasorelaxant agents. , 2010, European journal of medicinal chemistry.
[59] G. Bhatia,et al. Design and synthesis of novel indole-chalcone fibrates as lipid lowering agents. , 2014, European journal of medicinal chemistry.
[60] M. Rueping,et al. Continuous-flow hydration–condensation reaction: Synthesis of α,β-unsaturated ketones from alkynes and aldehydes by using a heterogeneous solid acid catalyst , 2011, Beilstein journal of organic chemistry.
[61] S. Horwitz,et al. Targeting histone deacetylases in T-cell lymphoma , 2017, Leukemia & lymphoma.
[62] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[63] F. J. Luque,et al. Protein flexibility and ligand recognition: challenges for molecular modeling. , 2011, Current topics in medicinal chemistry.
[64] Charles H Reynolds,et al. Impact of computational structure-based methods on drug discovery. , 2014, Current pharmaceutical design.
[65] A. Tafi,et al. Pharmacophore modelling: a forty year old approach and its modern synergies. , 2011, Current medicinal chemistry.
[66] Anne E Carpenter,et al. Discovery of New Anti-Schistosomal Hits by Integration of QSAR-Based Virtual Screening and High Content Screening. , 2016, Journal of medicinal chemistry.
[67] J. Chen,et al. Design, Synthesis, and Biological Evaluation of Prenylated Chalcones as Vasorelaxant Agents , 2009, Archiv der Pharmazie.
[68] N. Duran,et al. Synthesis and anti-proliferative activity of fluoro-substituted chalcones. , 2016, Bioorganic & medicinal chemistry letters.
[69] Mark McGann,et al. FRED and HYBRID docking performance on standardized datasets , 2012, Journal of Computer-Aided Molecular Design.
[70] Gisbert Schneider,et al. Computer-based de novo design of drug-like molecules , 2005, Nature Reviews Drug Discovery.
[71] C. G. Mohan,et al. Antiobesity and lipid lowering effects of Glycyrrhiza chalcones: experimental and computational studies. , 2011, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[72] Suengmok Cho,et al. Isoliquiritigenin, a chalcone compound, is a positive allosteric modulator of GABAA receptors and shows hypnotic effects. , 2011, Biochemical and biophysical research communications.
[73] M. R. Senger,et al. Filtering promiscuous compounds in early drug discovery: is it a good idea? , 2016, Drug discovery today.
[74] Haiyan Chen,et al. Tubulin inhibitors: pharmacophore modeling, virtual screening and molecular docking , 2014, Acta Pharmacologica Sinica.
[75] Markus Sitzmann,et al. Software and resources for computational medicinal chemistry. , 2011, Future medicinal chemistry.
[76] Matthew P. Repasky,et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.
[77] Y. Wu,et al. Highly Selective Continuous-Flow Synthesis of Potentially Bioactive Deuterated Chalcone Derivatives. , 2015, ChemPlusChem.
[78] Ricardo L. Mancera,et al. Ligand-Protein Docking with Water Molecules , 2008, J. Chem. Inf. Model..
[79] J. Deslypere. Clinical implications of the biopharmaceutical properties of fluvastatin. , 1994, The American journal of cardiology.
[80] Tycho Heimbach,et al. Prodrugs: design and clinical applications , 2008, Nature Reviews Drug Discovery.
[81] K. Sonogashira,et al. A Convenient Synthesis of Ethynylarenes and Diethynylarenes , 1980 .
[82] Thomas E. Exner,et al. pKa based protonation states and microspecies for protein–ligand docking , 2010, J. Comput. Aided Mol. Des..
[83] Emil Alexov,et al. The role of protonation states in ligand-receptor recognition and binding. , 2013, Current pharmaceutical design.
[84] Hege S. Beard,et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.
[85] W. Hagmann,et al. The many roles for fluorine in medicinal chemistry. , 2008, Journal of medicinal chemistry.
[86] Dwipen Kakati,et al. Microwave assisted solvent free synthesis of 1,3-diphenylpropenones , 2011, Chemistry Central journal.
[87] Alexander D. MacKerell,et al. All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.
[88] C. Xing,et al. Diverse Molecular Targets for Chalcones with Varied Bioactivities , 2015, Medicinal chemistry.
[89] A. Nadhman,et al. Drug resistance in leishmaniasis: current drug-delivery systems and future perspectives. , 2013, Future medicinal chemistry.
[90] J. Schwöbel,et al. Prediction of michael-type acceptor reactivity toward glutathione. , 2010, Chemical research in toxicology.
[91] Eugene N Muratov,et al. Per aspera ad astra: application of Simplex QSAR approach in antiviral research. , 2010, Future medicinal chemistry.
[92] Peter Ertl,et al. Bioisosteric Replacement and Scaffold Hopping in Lead Generation and Optimization , 2010, Molecular informatics.
[93] B. Grygiel-Górniak. Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications – a review , 2014, Nutrition Journal.
[94] Jung-Hsin Lin. Accommodating protein flexibility for structure-based drug design. , 2011, Current topics in medicinal chemistry.
[95] Michelle L Coote,et al. Molecular dynamics-driven drug discovery: leaping forward with confidence. , 2017, Drug discovery today.
[96] Bruce Tidor,et al. Systematic placement of structural water molecules for improved scoring of protein-ligand interactions. , 2011, Protein engineering, design & selection : PEDS.
[97] Kunal Roy,et al. How far can virtual screening take us in drug discovery? , 2013, Expert opinion on drug discovery.
[98] Arieh Warshel,et al. Progress in ab initio QM/MM free-energy simulations of electrostatic energies in proteins: accelerated QM/MM studies of pKa, redox reactions and solvation free energies. , 2009, The journal of physical chemistry. B.
[99] Enrico Glaab,et al. Building a virtual ligand screening pipeline using free software: a survey , 2015, Briefings Bioinform..
[100] L. M. Lima,et al. Bioisosterism: a useful strategy for molecular modification and drug design. , 2005, Current medicinal chemistry.
[101] J. Baell,et al. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. , 2010, Journal of medicinal chemistry.
[102] Fatih Köksal,et al. New drugs for the treatment of Mycobacterium tuberculosis infection. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[103] Vladimir N. Vapnik,et al. The Nature of Statistical Learning Theory , 2000, Statistics for Engineering and Information Science.
[104] C. Andrade,et al. QSAR and QM/MM approaches applied to drug metabolism prediction. , 2012, Mini reviews in medicinal chemistry.
[105] R. Beltramino,et al. An Open-Label, Randomized Multicenter Study Comparing the Efficacy and Safety of Cyclo 3 Fort® Versus Hydroxyethyl Rutoside in Chronic Venous Lymphatic Insufficiency , 2000, Angiology.
[106] K. Tominaga,et al. Sofalcone, a gastroprotective drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori: A randomized controlled comparative trial with cimetidine, an H2‐receptor antagonist , 2010, Journal of gastroenterology and hepatology.
[107] C. Andrade,et al. Computer-aided discovery of two novel chalcone-like compounds active and selective against Leishmania infantum. , 2017, Bioorganic & medicinal chemistry letters.
[108] R. Ertan,et al. Chemical and Structural Properties of Chalcones I , 2014 .
[109] Luigi Vaccaro,et al. Polystyryl-supported TBD as an efficient and reusable catalyst under solvent-free conditions. , 2004, Chemical communications.
[110] M. Banach,et al. The role of fibrate treatment in dyslipidemia: an overview. , 2013, Current pharmaceutical design.
[111] Eugene Muratov,et al. QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activity. , 2017, European journal of medicinal chemistry.
[112] J. Bajorath,et al. State-of-the-art in ligand-based virtual screening. , 2011, Drug discovery today.
[113] M. Jordan,et al. Microtubules as a target for anticancer drugs , 2004, Nature Reviews Cancer.
[114] L. Dahners,et al. Effect of ciprofloxacin on the proliferation of osteoblast‐like MG‐63 human osteosarcoma cells in vitro , 1998, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[115] Teruaki Akao,et al. Isoliquiritigenin, one of the antispasmodic principles of Glycyrrhiza ularensis roots, acts in the lower part of intestine. , 2007, Biological & pharmaceutical bulletin.
[116] J. Schwabe,et al. Targeting Class I Histone Deacetylases in a "Complex" Environment. , 2017, Trends in pharmacological sciences.
[117] E. Proschak,et al. Structure‐Based Pharmacophores for Virtual Screening , 2011, Molecular informatics.
[118] C. Andrade,et al. Modern approaches to accelerate discovery of new antischistosomal drugs , 2016, Expert opinion on drug discovery.
[119] Ruibo Wu,et al. A proton-shuttle reaction mechanism for histone deacetylase 8 and the catalytic role of metal ions. , 2010, Journal of the American Chemical Society.
[120] Steven W. Muchmore,et al. High-Throughput Calculation of Protein-Ligand Binding Affinities: Modification and Adaptation of the MM-PBSA Protocol to Enterprise Grid Computing , 2006, J. Chem. Inf. Model..
[121] Brian S. Fulton,et al. Glossary of Terms Used in Medicinal Chemistry , 2014 .
[122] Vivek Asati,et al. Chalcone scaffolds as anti-infective agents: structural and molecular target perspectives. , 2015, European journal of medicinal chemistry.
[123] D. Rognan. Chemogenomic approaches to rational drug design , 2007, British journal of pharmacology.
[124] Prasenjit Mukherjee,et al. An overview of molecular fingerprint similarity search in virtual screening , 2016, Expert opinion on drug discovery.
[125] Zhilong Xiu,et al. Rescoring ligand docking poses. , 2010, Current opinion in drug discovery & development.
[126] N. Lawrence,et al. The interaction of chalcones with tubulin. , 2000, Anti-cancer drug design.
[127] J. Dearden,et al. QSAR modeling: where have you been? Where are you going to? , 2014, Journal of medicinal chemistry.
[128] T. Müller,et al. Coupling-isomerization synthesis of chalcones. , 2006, Chemistry.
[129] Adrià Cereto-Massagué,et al. Molecular fingerprint similarity search in virtual screening. , 2015, Methods.
[130] C. Xia,et al. Efficient Coupling Reactions of Arylalkynes and Aldehydes Leading to the Synthesis of Enones , 2004 .
[131] K. Park,et al. Quantitative analysis of phenolic metabolites from different parts of Angelica keiskei by HPLC-ESI MS/MS and their xanthine oxidase inhibition. , 2014, Food chemistry.
[132] X. Daura,et al. Parametrization of aliphatic CHn united atoms of GROMOS96 force field , 1998 .
[133] R. Yunes,et al. Biological Evaluation of Chalcones and Analogues as Hypolipidemic Agents , 2006, Archiv der Pharmazie.
[134] C. A. Fraga. Drug hybridization strategies: before or after lead identification? , 2009, Expert opinion on drug discovery.
[135] P. Kumar,et al. Leishmania donovani pteridine reductase 1: biochemical properties and structure-modeling studies. , 2008, Experimental parasitology.
[136] Markus A Lill,et al. Induced fit docking, and the use of QM/MM methods in docking. , 2013, Drug discovery today. Technologies.
[137] Yuko Okamoto,et al. QM/MM free energy simulations: recent progress and challenges , 2016, Molecular simulation.
[138] Stefano Forli,et al. Virtual screening with AutoDock: theory and practice , 2010, Expert opinion on drug discovery.
[139] E. Rubinstein,et al. In vitro effects of ciprofloxacin and pefloxacin on growth of normal human hematopoietic progenitor cells and on leukemic cell lines. , 1989, The Journal of pharmacology and experimental therapeutics.
[140] Stephani Joy Y Macalino,et al. Role of computer-aided drug design in modern drug discovery , 2015, Archives of Pharmacal Research.
[141] Carmenza Spadafora,et al. Malarial hemozoin: from target to tool. , 2014, Biochimica et biophysica acta.
[142] P. Kollman,et al. A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .
[143] Guigang Zhang,et al. Deep Learning , 2016, Int. J. Semantic Comput..
[144] Yi-Ping Phoebe Chen,et al. Structure-based drug design to augment hit discovery. , 2011, Drug discovery today.
[145] C. Wan,et al. Synthesis and biological evaluation of novel hybrid compounds between chalcone and piperazine as potential antitumor agents , 2016 .
[146] Carolina H Andrade,et al. Assessing the performance of 3D pharmacophore models in virtual screening: how good are they? , 2013, Current topics in medicinal chemistry.
[147] Donald J Abraham,et al. Structure-based drug design strategies in medicinal chemistry. , 2009, Current topics in medicinal chemistry.
[148] P. Martorana,et al. Cardiovascular actions of the furoxan CAS 1609, a novel nitric oxide donor , 1995, British journal of pharmacology.
[149] Anne E Carpenter,et al. QSAR-Driven Discovery of Novel Chemical Scaffolds Active against Schistosoma mansoni , 2016, J. Chem. Inf. Model..
[150] Amedeo Caflisch,et al. Quantum mechanical methods for drug design. , 2010, Current topics in medicinal chemistry.
[151] R. Beltramino,et al. An open-label, randomised multicentre study comparing the efficacy and safety of CYCLO 3 FORT versus hydroxyethyl rutoside in chronic venous lymphatic insufficiency. , 1999, International angiology : a journal of the International Union of Angiology.
[152] A. Brancale,et al. Design, synthesis, and biological evaluation of thiophene analogues of chalcones. , 2008, Bioorganic & medicinal chemistry.
[153] E. Lionta,et al. Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances , 2014, Current topics in medicinal chemistry.
[154] J. Berman,et al. Advances in leishmaniasis , 2005, The Lancet.
[155] S. Christensen,et al. Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania , 1993, Antimicrobial Agents and Chemotherapy.
[156] R. Fruttero,et al. A new class of furoxan derivatives as NO donors: mechanism of action and biological activity , 1995, British journal of pharmacology.
[157] Simon Feldbaek Nielsen,et al. Antibacterial chalcones--bioisosteric replacement of the 4'-hydroxy group. , 2004, Bioorganic & medicinal chemistry.
[158] A Burger,et al. Isosterism and bioisosterism in drug design. , 1991, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.